Felicia Forma, BSc

Antidepressant and Psychotherapy Treatment among Patients With Major Depressive Disorder and an Elevated PHQ-9 Score

Background The PHQ-9 measures depression symptom severity and is recommended for use in clinical practice among patients with major depressive disorder (MDD). Objective To describe treat...

Charles Ruetsch , PhD;

Joshua Liberman , PhD;

Felicia Forma , BSc;

Pinyao Rui , PhD;

Alberto Batista , PharmD;

10/08/2020

The Cost of Improving Treatment Choices: Cost and Benefit of a Digital Medicine System that Collects and Reports Objective Medication Adherence

Background: Medication adherence is critical for relapse prevention among SMI patients. In the absence of objectively collected adherence data (OCAD), managing medications is difficult. A...

Felicia Forma , BSc;

Christopher P. Young , MD, PhD;

Charles Ruetsch , PhD;

Heidi Waters , PhD, MBA;

11/22/2019

Implementation of Digital Health Technologies for Real-time Monitoring of Patients With Serious Mental Illness: What Lessons Can Be Learned and Applied From Other Specialties?

Introduction: Evaluation of patients with serious mental illness (SMI) relies largely on patient or caregiver self-reported disease symptoms. New technologies (e.g., mobile-based interven...

Felicia Forma , BSc;

Caroline Huber , MPH;

Wade Aubry , MD;

Darius Lakdawalla , PhD;

John Kane , MD;

Jason Shafrin , PhD;

Meaghan Roach , MPH;

Suepattra G. May , MPH, PhD;

11/22/2019

A Comparison of Barriers and Drivers Between Prescribing and Non-Prescribing Psychiatric Care Providers Regarding Use of Digital Medication Adherence Platforms

Background: Tracking medication adherence through an ingestible event monitoring (IEM) sensor could benefit seriously mentally ill patients (SMI). Psychiatric providers may be reluctant t...

Jennifer Clerie , BS ;

Charles Ruetsch , PhD;

Heidi Waters , PhD, MBA;

Tigwa Davis , PhD;

Dawn Velligan , PhD;

Delbert Robinson , MD;

Chris Jaeger , MD, MBA;

William Carpenter , MD;

Joshua Liberman , PhD;

Felicia Forma , BSc;

11/22/2019

Barriers and Drivers of Adopting a Digital Medication Adherence Technology: Understanding the Factor Analysis Results

Background: A new digital medicine technology combining an ingestible event monitoring (IEM) sensor with an oral antipsychotic to track ingestion and adherence may be beneficial. However,...

William Carpenter , MD;

Joshua Liberman , PhD;

Felicia Forma , BSc;

Charles Ruetsch , PhD;

Jennifer Clerie , BS ;

Tigwa Davis , PhD;

Heidi Waters , PhD, MBA;

Dawn Velligan , PhD;

Delbert Robinson , MD;

Chris Jaeger , MD, MBA;

11/22/2019

The Frameworks to Support Adherence in Mental Health Working Group: Translating Science Into Action to Improve Patient Care

Shared decision making (SDM) involves healthcare providers and patients collaborating to make optimal healthcare decisions that align with patients’ goals and values. Patient decision aid...

Heidi Waters , PhD, MBA;

Dawn Velligan , PhD;

Felicia Forma , BSc;

Susan Bergeson ;

Martha Sajatovic , MD;

Jason Caplan , MD;

Michael Measom , MD;

Monica Oss , MS;

Michael Townsend , MA;

03/01/2019

Antipsychotic Treatment Communication Patterns: Predictors and Follow-up Risk

Discussing treatment compliance is challenging when patients have serious mental illness. Little is known about compliance-related discussions between healthcare providers and patients. ...

Heidi Waters , PhD, MBA;

Carolyn Martin , MSW;

John P. White , MD, DPM, MS;

Eleena Koep , MS;

Angela Belland , BS ;

Felicia Forma , BSc;

03/01/2019